Abstract

947P - Subgroup analysis of rucaparib in platinum-sensitive recurrent ovarian carcinoma: Effect of prior chemotherapy regimens in ARIEL3

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma
Kristopher J Kimball ... Ronald D Alvarez
Gynecologic oncology | VOL. 111
Kristopher J Kimball, et. al.Kristopher J Kimball ... Ronald D Alvarez
08 Aug 2008
Exploratory analysis of the effect of maintenance rucaparib on postprogression outcomes in patients (pts) with platinum-sensitive recurrent ovarian carcinoma (OC) and updated safety data from the phase 3 study ARIEL3.
Robert L Coleman ...
Journal of Clinical Oncology | VOL. 37
Robert L Coleman, et. al.Robert L Coleman ...
20 May 2019
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study
A.J González-Martín ... A Cervantes
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 16
A.J González-Martín, et. al.A.J González-Martín ... A Cervantes
07 Apr 2005
Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China.
Jing Nie ... Lei Sun
Frontiers in Pharmacology | VOL. 13
Jing Nie, et. al.Jing Nie ... Lei Sun
04 Jan 2023
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma.
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
B Eichhorst ... C Buske
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
B Eichhorst, et. al.B Eichhorst ... C Buske
01 Jul 2024
View more papers